MDL-100240
MDL-100240 is a dual-acting angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) inhibitor. MDL-100240 can significantly lower blood pressure, reverse left ventricular hypertrophy, and effectively prevent hypertrophy and dilatation of the aorta and resistance arteries, with an effect comparable to that of ramipril. In addition, MDL-100240 can also reduce aldosterone levels, but has no significant effect on atrial natriuretic peptide and cGMP. In 3-month-old transgenic rats, MDL-100240 can reduce adrenomedullin concentrations, prevent and reverse severe hypertension and cardiovascular damage, and enhance bradykinin effects.
Product Specifications
CAS Number
142695-08-7
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE) ; Neprilysin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/mdl-100240.html
Smiles
O=C(O)[C@@H]1CCC[C@@]([H])(N1C2=O)C3=CC=CC=C3C[C@@H]2NC([C@H](CC4=CC=CC=C4)SC(C)=O)=O
Molecular Formula
C26H28N2O5S
Molecular Weight
480.58
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bacillus subtilis subsp. natto Subtilisin NAT (aprN)
Recombinant Bacillus subtilis subsp. natto Subtilisin NAT (aprN)
Recombinant Bacillus subtilis subsp. natto Subtilisin NAT (aprN)
Recombinant Bacillus subtilis subsp. natto Subtilisin NAT (aprN)
Anti-Human Complement C5b-9 Complex Antibody (aE11#), PerCP